Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Strasser

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
European Journal of Medicinal Chemistry|August 31, 2025
Development of potent glutathione transferase Omega-1 inhibitors with applications in inflammation and cancer therapyYiyue Xie, Yuji Nakano, Padmaja Tummala, et al.
Archiv Der Pharmazie|June 1, 2022
Characterization of caspase-2 inhibitors based on specific sites of caspase-2-mediated proteolysisMerlin Bresinsky, Jessica M Strasser, Alexander Hubmann, et al.
Journal of Medicinal Chemistry|February 28, 2020
Development of Benzenesulfonamide Derivatives as Potent Glutathione Transferase Omega-1 InhibitorsYiyue Xie, Padmaja Tummala, Aaron J Oakley, et al.
Journal of Hepatology|November 9, 2010
Characterization of CD8+ T-cell response in acute and resolved hepatitis A virus infectionI Schulte, T Hitziger, S Giugliano, et al.
ACS Chemical Neuroscience|May 6, 2022
Caspase-2 Inhibitor Blocks Tau Truncation and Restores Excitatory Neurotransmission in Neurons Modeling FTDP-17 TauopathyGurpreet Singh, Peng Liu, Katherine R Yao, et al.
ACS Pharmacology & Translational Science|January 21, 2022
Structure-Based Design and Biological Evaluation of Novel Caspase-2 Inhibitors Based on the Peptide AcVDVAD-CHO and the Caspase-2-Mediated Tau Cleavage Sequence YKPVD314Merlin Bresinsky, Jessica M Strasser, Bernadette Vallaster, et al.
Nature Communications|November 17, 2017
Assay interference and off-target liabilities of reported histone acetyltransferase inhibitorsJayme L Dahlin, Kathryn M Nelson, Jessica M Strasser, et al.
BMC Psychiatry|February 2, 2020
Chronic pain diagnoses and opioid dispensings among insured individuals with serious mental illnessAshli Owen-Smith, Christine Stewart, Musu M Sesay, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 13, 2016
The contribution of the European high containment laboratories during the 2014-2015 Ebola Virus Disease emergencyC Nisii, D Vincenti, F M Fusco, et al.
Journal of Medicinal Chemistry|February 5, 2019
3,3'-Disubstituted 5,5'-Bi(1,2,4-triazine) Derivatives with Potent in Vitro and in Vivo Antimalarial ActivityLian Xue, Da-Hua Shi, Jitendra R Harjani, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
European Journal of Medicinal Chemistry|August 31, 2025
Development of potent glutathione transferase Omega-1 inhibitors with applications in inflammation and cancer therapyYiyue Xie, Yuji Nakano, Padmaja Tummala, et al.
Archiv Der Pharmazie|June 1, 2022
Characterization of caspase-2 inhibitors based on specific sites of caspase-2-mediated proteolysisMerlin Bresinsky, Jessica M Strasser, Alexander Hubmann, et al.
Journal of Medicinal Chemistry|February 28, 2020
Development of Benzenesulfonamide Derivatives as Potent Glutathione Transferase Omega-1 InhibitorsYiyue Xie, Padmaja Tummala, Aaron J Oakley, et al.
Journal of Hepatology|November 9, 2010
Characterization of CD8+ T-cell response in acute and resolved hepatitis A virus infectionI Schulte, T Hitziger, S Giugliano, et al.
ACS Chemical Neuroscience|May 6, 2022
Caspase-2 Inhibitor Blocks Tau Truncation and Restores Excitatory Neurotransmission in Neurons Modeling FTDP-17 TauopathyGurpreet Singh, Peng Liu, Katherine R Yao, et al.
ACS Pharmacology & Translational Science|January 21, 2022
Structure-Based Design and Biological Evaluation of Novel Caspase-2 Inhibitors Based on the Peptide AcVDVAD-CHO and the Caspase-2-Mediated Tau Cleavage Sequence YKPVD314Merlin Bresinsky, Jessica M Strasser, Bernadette Vallaster, et al.
Nature Communications|November 17, 2017
Assay interference and off-target liabilities of reported histone acetyltransferase inhibitorsJayme L Dahlin, Kathryn M Nelson, Jessica M Strasser, et al.
BMC Psychiatry|February 2, 2020
Chronic pain diagnoses and opioid dispensings among insured individuals with serious mental illnessAshli Owen-Smith, Christine Stewart, Musu M Sesay, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 13, 2016
The contribution of the European high containment laboratories during the 2014-2015 Ebola Virus Disease emergencyC Nisii, D Vincenti, F M Fusco, et al.
Journal of Medicinal Chemistry|February 5, 2019
3,3'-Disubstituted 5,5'-Bi(1,2,4-triazine) Derivatives with Potent in Vitro and in Vivo Antimalarial ActivityLian Xue, Da-Hua Shi, Jitendra R Harjani, et al.
Pageof 13